Browse the corpus

Alveolar macrophages, also known as dust cells, are phagocytic cells that play a crucial role in the immune defense of the respiratory system (see Image. Alveolar Macrophage). As part of the innate immune system, alveolar macrophages serve as the first line of defense against inhaled pathogens and particulate matter in the pulmonary alveoli and interalveolar septae near pneumocytes. The alveoli, the terminal units of the respiratory system, are responsible for gas exchange between the lungs and the bloodstream. The alveolar structure consists of 3 primary cell types. Type I pneumocytes form the alveolar wall and are essential for gas exchange, covering approximately 95% of the alveolar surface. Type I pneumocytes cannot replicate.[1] Type II pneumocytes secrete pulmonary surfactant, a lipoprotein that lowers surface tension, preventing alveolar collapse during exhalation. Additionally, type II pneumocytes function as progenitor cells, capable of differentiating into either type I or new type II pneumocytes in response to injury, which is crucial for maintaining the structural integrity and function of the alveoli.[2][3] Alveolar macrophages function as vital immune cells, clearing the alveoli of debris and pathogens through phagocytosis while producing cytokines and chemokines to recruit and activate other immune cells.[4] These roles make them pivotal in maintaining both immune defense and tissue homeostasis.[5] Alveolar macrophages are also essential for tissue remodeling and repair.[6] All cells from the mononuclear phagocyte system originate from hematopoietic stem cells in the bone marrow, which give rise to both myeloid and lymphoid progenitors.[7] Common myeloid progenitors differentiate into various myeloid cells, including granulocyte-monocyte progenitors, which further develop into monocytes.[8] Monocytes circulate in the bloodstream and subsequently migrate into tissues, differentiating into macrophages.[9] However, specific tissue-resident macrophages, including alveolar macrophages in the lungs, may develop on-site during embryonic stages and maintain their population independently of circulating monocytes through local proliferation.[10][11] Monocytes have a short lifespan in the blood, typically around 1 to 3 days. In contrast, tissue macrophages, such as alveolar macrophages, can persist for months to years under steady-state conditions.[12][13]

Alveolar macrophages are central to maintaining lung homeostasis and immune defense, but alterations in their function can lead to various pathophysiological conditions. Alveolar macrophage dysregulation can contribute to both acute and chronic lung diseases through inappropriate immune activation, tissue damage, or impaired clearance of pathogens and debris. Immune Response Dysregulation In conditions such as chronic obstructive pulmonary disease (COPD) and asthma, alveolar macrophages can become excessively activated, producing large amounts of pro-inflammatory cytokines like TNF-α and interleukin-1β. This excessive immune response leads to chronic inflammation, airway remodeling, and tissue destruction. In COPD, alveolar macrophages also exhibit impaired phagocytic function, reducing their ability to clear pathogens and exacerbating infection risks. Surfactant Accumulation and Alveolar Proteinosis Alveolar macrophages are crucial in clearing excess pulmonary surfactant. In conditions like PAP, alveolar macrophage dysfunction leads to the accumulation of surfactant, impairing gas exchange and causing respiratory distress. Granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling, which is essential for the surfactant clearance function of alveolar macrophages, is defective. Fibrotic Responses and Lung Fibrosis Alveolar macrophages contribute to the development of pulmonary fibrosis by promoting excessive tissue remodeling and extracellular matrix deposition. In diseases like idiopathic pulmonary fibrosis, alveolar macrophages shift toward a profibrotic phenotype, secreting growth factors such as transforming growth factor-β and platelet-derived growth factor, which drive fibroblast activation and collagen deposition, ultimately leading to lung tissue scarring and loss of function. Impaired Phagocytosis in Acute Lung Injury Alveolar macrophages can become overwhelmed in acute conditions, such as acute respiratory distress syndrome (ARDS), leading to impaired clearance of pathogens and apoptotic cells. This dysfunction contributes to the persistence of inflammation and the development of diffuse alveolar damage, which characterizes acute respiratory distress syndrome. In such scenarios, macrophages may produce high levels of inflammatory cytokines and oxidative stress mediators, exacerbating lung injury. Walling Off of Bacteria

Alveolar macrophages can become overwhelmed in acute conditions, such as acute respiratory distress syndrome (ARDS), leading to impaired clearance of pathogens and apoptotic cells. This dysfunction contributes to the persistence of inflammation and the development of diffuse alveolar damage, which characterizes acute respiratory distress syndrome. In such scenarios, macrophages may produce high levels of inflammatory cytokines and oxidative stress mediators, exacerbating lung injury. Walling Off of Bacteria Alveolar macrophages play an essential role in tuberculosis infections. Mycobacterium tuberculosis has developed mechanisms that resist macrophage phagocytosis. Alveolar macrophages gather around  M tuberculosis and form a multinucleated giant cell, the Langerhans giant cell, surrounded by T-cells. TNF-α and interferon-γ are essential in forming granuloma.[40][41] Tuberculosis is one of the leading causes of mortality and morbidity in patients with HIV, especially in underdeveloped countries where highly active antiretroviral therapy is not widely available. Additionally, the hallmark finding of noncaseating granulomas in certain systemic diseases, such as sarcoidosis, results from alveolar macrophages aggregating to isolate the infectious process. Alveolar macrophages also secrete vitamin D, which can lead to hypercalcemia in sarcoidosis—a clinical criterion that aids in diagnosing the condition.[42][43] Alveolar macrophages also engulf environmental particles that harm them in the process. Carbon accumulation leading to a condition known as pneumoconiosis is often reported among coal mine workers. Crystalline silica particles can impair the immunologic response of alveolar macrophages, mimicking tuberculosis. For this reason, patients with a history of silica exposure should undergo periodic tuberculosis testing.